One day, a veterinarian was feeling ill and went to see her doctor. The doctor was asking the vet the usual questions--her symptoms, and how long she had been experiencing them--when she interrupted him.
"Hey look,” she said. “I'm a vet. I don't need to ask my patients these kinds of questions. I can tell what's wrong just by looking. Why can't you?"
The doctor nodded, looked her up and down, wrote out a prescription, and handed it to her. He said, "There you are. Of course, if that doesn't work, we'll have to put you down."
Like the vet, a chief information security officer (CISO) knows a thing or two about security. And like the vet who hopes a prescription will eliminate her symptoms, the CISO buys an (N+1) cyber security solution from an (N+100) promising vendor, hoping it will work. A breach, of course, is the worst that could happen. He can’t afford the system’s downfall. So he invests in more security.
And that’s where Cymptom comes in. Matan Hart and Itamar Mizrahi founded Cymptom because they couldn’t bear to compromise multi-billion dollar security defenses. Instead of offering yet another solution that may only temporarily relieve the pain, Cymptom empowers businesses to self-heal by optimizing the existing security architecture. Cymptom determines which security gaps are most likely to be exploited in real time. They then offer the best mitigation to make the business resilient to cyber threats. Their unique solution is the first to map all breach scenarios without simulating attacks or interfering with existing security controls.
For us at SOMV, the decision to invest in Cymptom was purely ROI (return on investment). Not ours (though we certainly hope so), but that of its customers. For a software market to grow from a few billion dollars annually to more than a hundred billion in less than 15 years means enterprises have a huge sinking cost. With about a trillion behind and another trillion ahead in the next five years, Cymptom allows them to dramatically increase ROI with no agents, no disruption and no headache.